Back to Results
First PageMeta Content
Immune system / Immunology / T cells / Cancer treatments / Programmed cell death protein 1 / Regulatory T cell / Interferon gamma / Immunotherapy / LAG3 / Immune checkpoint / CD4+ T cells and antitumor immunity / Interleukin 21


ASCO Annual Meeting - Chicago, IL, May 29 –June 2, 2015; Abstract #3017 Poster #: 343 A first-in-human dose escalation study of PEGylated recombinant human IL-10 (AM0010) in advanced solid tumors. Jeffrey R. Infante1,
Add to Reading List

Document Date: 2015-12-11 00:15:33


Open Document

File Size: 1,59 MB

Share Result on Facebook